A covering method for detecting genetic associations between rare variants and common phenotypes
Gaurav Bhatia1, Vikas Bansal, Olivier Harismendy
1Department of Computer Science and Engineering, University of California San Diego, La Jolla, California, USA. gbhatia@mit.edu
Plos Computational Biology
|October 27, 2010
Summary
This study introduces RareCover, a novel algorithm for analyzing rare variants (RVs) in genetic association studies. RareCover effectively identifies RVs influencing disease risk, improving upon existing methods for complex genetic traits.
Area of Science:
- Genetics
- Bioinformatics
- Computational Biology
Background:
- Genome-wide association (GWA) studies often struggle to identify associations with common variants.
- Multiple rare variants (RVs) may collectively influence disease etiology, posing a challenge for traditional GWA approaches.
Purpose of the Study:
- To develop and validate a new algorithm, RareCover, for detecting associations involving multiple rare variants.
- To assess the performance of RareCover compared to existing methods like collapsing and weighted-collapsing strategies.
Main Methods:
- Developed RareCover, an algorithm that aggregates disparate rare variants with low effect and modest penetrance, irrespective of their genomic location.
- Conducted extensive simulations to evaluate RareCover's power across various penetrance and population attributable risk (PAR) values.
- Applied RareCover to re-sequencing data from individuals with extreme Body Mass Index (BMI) values, focusing on FAAH and MGLL genes.
Main Results:
- Simulations demonstrated RareCover's superior power over collapsing-based methods.
- Analysis of BMI cohort data identified significant associations in the upstream regulatory regions of FAAH and MGLL genes.
- These associations suggest that rare variants disrupt gene expression, impacting cannabinoid metabolism.
Conclusions:
- RareCover offers a powerful approach for identifying genetic associations involving rare variants.
- Incorporating rare variants into genetic association studies is crucial for a comprehensive understanding of disease etiology.
- The findings highlight the potential role of rare variants in metabolic regulation and complex traits like obesity.
More Related Videos
Related Concept Videos
Genome-wide Association Studies-GWAS
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Principles of Pharmacogenetics: Types of Genetic Variants
The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
Comparing Copy Number Variations and SNPs
Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...
Genetic Screens
Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Epistasis Analysis
Although Mendel chose seven unrelated traits in peas to study gene segregation, most traits involve multiple gene interactions that create a spectrum of phenotypes. When the interaction of various genes or alleles at different locations influences a phenotype, this is called epistasis. Epistasis often involves one gene masking or interfering with the expression of another (antagonistic epistasis). Epistasis often occurs when different genes are part of the same biochemical pathway. The...


